|
Tabla 2: Análisis bivariado entre el índice de masa corporal y variables de interés. |
|||||
|
Sobrepeso N = 72 n (%) |
Obesidad |
p |
|||
|
I N = 18 n (%) |
II N = 7 n (%) |
III N = 3 n (%) |
|||
|
Sexo |
|||||
|
Masculino Femenino |
34 (47.2) 38 (52.7) |
10 (55.5) 8 (44.4) |
5 (71.4) 2 (28.5) |
0 (0.0) 3 (100.0) |
0.023 |
|
ASA |
|||||
|
I II IV |
5 (6.9) 67 (93.0) 0 (0.0) |
1 (5.5) 17 (94.4) 0 (0.0) |
0 (0.0) 6 (85.7) 1 (14.2) |
0 (0.0) 3 (100.0) 0 (0.0) |
0.107 |
|
Tipo de anestesia |
|||||
|
Anestesia general balanceda Anestesia total intravenosa Regional Bloqueo subaracnoideo Bloqueo mixto Sedación |
31 (43.0) 12 (16.6) 1 (1.3) 20 (27.7) 3 (4.1) 5 (6.9) |
10 (55.5) 3 (16.6) 1 (5.5) 4 (22.2) 0 (0.0) 0 (0.0) |
4 (57.1) 1 (14.2) 0 (0.0) 2 (28.5) 0 (0.0) 0 (0.0) |
1 (33.3) 0 (0.0) 0 (0.0) 2 (66.6) 0 (0.0) 0 (0.0) |
0.968 |
|
Profilaxis NVPO |
|||||
|
Dexametasona Metoclopramida Ondansetrón Ninguno |
35 (48.6) 1 (1.38) 28 (38.8) 8 (11.1) |
10 (55.5) 0 (0.0) 8 (44.4) 0 (0.0) |
4 (57.1) 0 (0.0) 2 (28.5) 1 (14.2) |
1 (33.3) 1 (33.3) 1 (33.3) 0 (0.0) |
0.042 |
|
ASA = clasificación de la American Society of Anesthesiologists. NVPO = incidencia de náuseas y vómitos postoperatorios. |
|||||